PsychRounds: The Psychiatry Podcast

Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.

References:
https://pubmed.ncbi.nlm.nih.gov/41632432/
https://pubmed.ncbi.nlm.nih.gov/42198294/
https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/

Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.

Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42247271/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205
https://pubmed.ncbi.nlm.nih.gov/42070571
https://pubmed.ncbi.nlm.nih.gov/41806782/

We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.

References:
https://pubmed.ncbi.nlm.nih.gov/12778843/
https://pubmed.ncbi.nlm.nih.gov/19880458/
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026
https://pubmed.ncbi.nlm.nih.gov/15061154/
https://pubmed.ncbi.nlm.nih.gov/20370962/
https://pubmed.ncbi.nlm.nih.gov/37491091/

We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.

Dr. Nancy Gee Profile: https://medschool.vcu.edu/about/portfolio/details/geen2/

References:
Dogs Supporting Human Health and Well-Being: A Biopsychosocial Approach: 
https://pubmed.ncbi.nlm.nih.gov/33860004/
Randomized Controlled Trials: https://pmc.ncbi.nlm.nih.gov/articles/PMC12728353/, https://pmc.ncbi.nlm.nih.gov/articles/PMC11714157/